[18F]FDG PET/CT beyond staging: Prognostic significance of sarcopenia and adipose tissue metabolism in esophageal carcinomas

This publication has 35 references indexed in Scilit:

• Role of body composition and metabolic parameters extracted from baseline 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma
  Annals of Hematology, 2023
• The validation of low-dose CT scans from the [18F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans
  European Journal of Nuclear Medicine and Molecular Imaging, 2023
• Role of 18F-FDG PET/CT and sarcopenia in untreated non-small cell lung cancer with advanced stage
  Japanese Journal of Radiology, 2022
• Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta‐analysis
  Journal of Cachexia, Sarcopenia and Muscle, 2022
• Sarcopenia: imaging assessment and clinical application
  Abdominal Radiology, 2021
• Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2021
• Visceral adipose tissue volume and CT‐attenuation as prognostic factors in patients with head and neck cancer
  Head & Neck, 2019
• Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content
  Clinical Nutrition, 2016
• Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies
  British Journal of Surgery, 2015
• Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer
  European Radiology, 2014